P A Speth
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 4
-
- Chemotherapy-induced cardiotoxicity and mitigation 9
- Co-authors
- C. Haanen (11 shared papers)Q.G.C.M. van Hoesel (1 shared paper)P. Linssen (10 shared papers)H. Wessels (5 shared papers)J.B.M. Boezeman (5 shared papers)Timothy J. Kinsella (4 shared papers)C. B. H. W. Lamers (2 shared papers)Alfred E. Chang (3 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (3 papers)Cytometry (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Gut (2 papers)Heart (1 paper)
- Partner nations
- NetherlandsUnited StatesMalaysia
In The Last Decade
P A Speth
24 papers receiving 853 citations
Peers
Comparison fields: 5 of 100
- Oncology 309
- Cardiology and Cardiovascular Medicine 167
- Biomaterials 100
- Emergency Medicine 57
- Biophysics 30
Countries citing papers authored by P A Speth
This map shows the geographic impact of P A Speth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P A Speth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P A Speth more than expected).
Fields of papers citing papers by P A Speth
This network shows the impact of papers produced by P A Speth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P A Speth. The network helps show where P A Speth may publish in the future.
Co-authors
The 25 scholars most cited alongside P A Speth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 361 | |
| 2 | 1987 | 57 | |
| 3 | 1987 | 47 | |
| 4 | 1985 | 39 | |
| 5 | 1989 | 37 | |
| 6 | 1988 | 37 | |
| 7 | Idarubicin v daunorubicin: preclinical and clinical pharmacokinetic studies. | 1989 | 35 |
| 8 | 1985 | 33 | |
| 9 | 1986 | 33 | |
| 10 | 1983 | 28 | |
| 11 | 1989 | 25 | |
| 12 | 1988 | 24 | |
| 13 | 1986 | 22 | |
| 14 | Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study. | 1988 | 22 |
| 15 | 1988 | 21 | |
| 16 | 1986 | 16 | |
| 17 | 1987 | 15 | |
| 18 | 1987 | 12 | |
| 19 | 1989 | 12 | |
| 20 | 1987 | 11 |
About P A Speth
P A Speth is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 24 papers that have together received 906 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Cancer therapeutics and mechanisms (5 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Research Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Neuroblastoma Research and Treatments (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Oncology (309 citations), Cardiology and Cardiovascular Medicine (167 citations), Biomaterials (100 citations), Emergency Medicine (57 citations) and Biophysics (30 citations). P A Speth has collaborated with scholars based in Netherlands, United States and Malaysia. Frequent co-authors include C. Haanen, Q.G.C.M. van Hoesel, P. Linssen, H. Wessels, J.B.M. Boezeman, Timothy J. Kinsella, C. B. H. W. Lamers, Alfred E. Chang, Jerry M. Collins and Hans Minderman. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Cytometry, Cancer Chemotherapy and Pharmacology, Gut and Heart.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.